Retrovirus silencing by an epigenetic TRIM.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 17923079)

Published in Cell on October 05, 2007

Authors

James Ellis1, Akitsu Hotta, Mojgan Rastegar

Author Affiliations

1: Developmental and Stem Cell Biology Program, SickKids Hospital, Toronto, Ontario, Canada. jellis@sickkids.ca

Articles by these authors

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell (2011) 6.71

Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet (2011) 1.87

Epigenetic control. J Cell Physiol (2009) 1.85

Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate. Stem Cell Reports (2013) 1.48

Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS One (2013) 1.34

Constitutive heterochromatin reorganization during somatic cell reprogramming. EMBO J (2011) 1.27

MEIS C termini harbor transcriptional activation domains that respond to cell signaling. J Biol Chem (2005) 1.11

MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS One (2009) 1.09

Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat (2010) 1.06

Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research. Neural Plast (2012) 1.02

Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells. Biochem Biophys Res Commun (2011) 1.01

Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet (2013) 0.98

Genetic correction using engineered nucleases for gene therapy applications. Dev Growth Differ (2013) 0.93

Beta-globin LCR and intron elements cooperate and direct spatial reorganization for gene therapy. PLoS Genet (2008) 0.91

Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer (2012) 0.88

Production of anti-prion scFv-Fc fusion proteins by recombinant animal cells. J Biosci Bioeng (2003) 0.88

Rett syndrome and MeCP2. Neuromolecular Med (2014) 0.87

Beta2-microglobulin induces caspase-dependent apoptosis in the CCRF-HSB-2 human leukemia cell line independently of the caspase-3, -8 and -9 pathways but through increased reactive oxygen species. Int J Cancer (2003) 0.87

The genetic and epigenetic journey of embryonic stem cells into mature neural cells. Front Genet (2012) 0.87

Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes. PLoS One (2012) 0.85

Interplay between chromatin and trans-acting factors regulating the Hoxd4 promoter during neural differentiation. J Biol Chem (2006) 0.85

Stereospecificity and PAX6 function direct Hoxd4 neural enhancer activity along the antero-posterior axis. Dev Biol (2006) 0.85

Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells. Ann Anat (2013) 0.84

Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells. Sci Rep (2013) 0.82

Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant. Oncogene (2002) 0.78

YY1 binds to regulatory element of chicken lysozyme and ovalbumin promoters. Cytotechnology (2006) 0.77

[Advances in genome editing technologies for treating muscular dystrophy.] Clin Calcium (2017) 0.75